Cargando…

Absolute quantification of microparticles by flow cytometry in ascites of patients with decompensated cirrhosis: a cohort study

BACKGROUND: Microparticles (MPs) are small (<1 μm) cell membrane-derived vesicles that are formed in response to cellular activation or early stages of apoptosis. Increased plasma MP levels have been associated with liver disease severity. Here we investigated the clinical impact of ascites MPs i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Engelmann, Cornelius, Splith, Katrin, Krohn, Sandra, Herber, Adam, Boehlig, Albrecht, Boehm, Stephan, Pratschke, Johann, Berg, Thomas, Schmelzle, Moritz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586054/ https://www.ncbi.nlm.nih.gov/pubmed/28877719 http://dx.doi.org/10.1186/s12967-017-1288-3

Ejemplares similares

Ascites’ neutrophil function is significantly impaired in patients with decompensated cirrhosis but can be restored by autologous plasma incubation
por: Engelmann, Cornelius, et al.
Publicado: (2016)

Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event
por: Balcar, Lorenz, et al.
Publicado: (2022)

Extended liver resection in mice: state of the art and pitfalls—a systematic review
por: Kamali, Can, et al.
Publicado: (2021)

Molecular quantification and differentiation of Candida species in biological specimens of patients with liver cirrhosis
por: Krohn, Sandra, et al.
Publicado: (2018)

Predictors of Refractory Ascites Development in Patients with Hepatitis B Virus-Related Cirrhosis Hospitalized to Control Ascitic Decompensation
por: Seo, Ju Hee, et al.
Publicado: (2013)

Evaluation of Serum-Derived Bovine Immunoglobulin Protein Isolate in Subjects With Decompensated Cirrhosis With Ascites
por: Stotts, Matthew J, et al.
Publicado: (2021)

G-CSF treatment in decompensated liver disease: a double-edged sword?
por: Engelmann, Cornelius, et al.
Publicado: (2022)

Treatment of refractory ascites with an automated low‐flow ascites pump in patients with cirrhosis
por: Stirnimann, G., et al.
Publicado: (2017)

Frequency, characteristics and impact of multiple consecutive nosocomial infections in patients with decompensated liver cirrhosis and ascites
por: Schultalbers, Marie, et al.
Publicado: (2020)

The value of ascitic neutrophil gelatinase‐associated lipocalin in decompensated liver cirrhosis with spontaneous bacterial peritonitis
por: Liu, Hua, et al.
Publicado: (2020)

Ascites re-compensation in HBV-related first decompensated cirrhosis after anti-viral therapy
por: Li, Mingyu, et al.
Publicado: (2023)

Diagnostic Biomarkers to Diagnose Acute Allograft Rejection After Liver Transplantation: Systematic Review and Meta-Analysis of Diagnostic Accuracy Studies
por: Krenzien, Felix, et al.
Publicado: (2019)

Ascites and Cirrhosis
por: Stott, Hugh
Publicado: (1911)

Resolution of ascites and hepatic encephalopathy and absence of variceal bleeding in decompensated hepatitis C virus cirrhosis patients
por: Romano, John, et al.
Publicado: (2018)

Ascites, refractory ascites and hyponatremia in cirrhosis
por: Fortune, Brett, et al.
Publicado: (2017)

HEP-Net opinion on the management of ascites and its complications in the setting of decompensated cirrhosis in the resource constrained environment of Pakistan
por: Ali, Bushra, et al.
Publicado: (2020)

Culture-Positive Spontaneous Ascitic Infection in Patients with Acute Decompensated Cirrhosis: Multidrug-Resistant Pathogens and Antibiotic Strategies
por: Liu, Jing, et al.
Publicado: (2020)

Operation for the Ascites of Cirrhosis
Publicado: (1899)

Ascites in Cirrhosis of the Liver
Publicado: (1905)

Laparoscopic liver resection: indications, limitations, and economic aspects
por: Schmelzle, Moritz, et al.
Publicado: (2020)

Angiogenic inflammation and formation of necrosis in the tumor microenvironment influence patient survival after radical surgery for de novo hepatocellular carcinoma in non-cirrhosis
por: Atanasov, Georgi, et al.
Publicado: (2019)

Improving Survival in Decompensated Cirrhosis
por: Mukerji, Amar Nath, et al.
Publicado: (2012)

Management options in decompensated cirrhosis
por: Shah, Neeral L, et al.
Publicado: (2015)

COVID-19 in decompensated cirrhosis
por: Rela, Mohamed, et al.
Publicado: (2020)

Decompensation of Cirrhosis: An Unusual Cause
por: Rudra, Omkar S, et al.
Publicado: (2022)

Role of ascitic prostaglandin E2 in diagnosis of spontaneous bacterial peritonitis and prediction of in-hospital mortality in patients with decompensated cirrhosis
por: Luo, Junli, et al.
Publicado: (2019)

SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation
por: Kaplan, David E., et al.
Publicado: (2021)

Hepatitis B Vaccination in Patients with Liver Cirrhosis Evaluated for Liver Transplantation – A Simple Intervention Ensures High Adherence
por: Herta, Toni, et al.
Publicado: (2019)

Safety of intermittent Pringle maneuver during minimally invasive liver resection in patients with hepatocellular carcinoma with and without cirrhosis
por: Ortiz Galindo, Santiago A., et al.
Publicado: (2021)

Ascitic Interleukin 6 Is Associated with Poor Outcome and Spontaneous Bacterial Peritonitis: A Validation in Critically Ill Patients with Decompensated Cirrhosis
por: Mayr, Ulrich, et al.
Publicado: (2020)

Guidelines on the management of ascites in cirrhosis
por: Aithal, Guruprasad P, et al.
Publicado: (2021)

Improving Survival in Patients with Decompensated Cirrhosis
por: Amarapurkar, Deepak, et al.
Publicado: (2011)

Ecto-Nucleotide Triphosphate Diphosphohydrolase-2 (NTPDase2) Deletion Increases Acetaminophen-Induced Hepatotoxicity
por: Feldbrügge, Linda, et al.
Publicado: (2020)

Risk factors for malignant transformation of hepatocellular adenoma to hepatocellular carcinoma: protocol for systematic review and meta-analysis
por: Thevathasan, Tharusan, et al.
Publicado: (2021)

Correlation of cell-free DNA plasma concentration with severity of non-alcoholic fatty liver disease
por: Karlas, Thomas, et al.
Publicado: (2017)

Long-Term Outcome after Liver Transplantation for Progressive Familial Intrahepatic Cholestasis
por: Gül-Klein, Safak, et al.
Publicado: (2021)

An evaluation of ascitic calprotectin for diagnosis of ascitic fluid infection in children with cirrhosis
por: Honar, Naser, et al.
Publicado: (2022)

Ascites in Early Alcoholic Cirrhosis of the Liver
por: Weber, F. Parkes
Publicado: (1903)

Management of Ascites in Patients with Cirrhosis: An Update
por: Zaccherini, Giacomo, et al.
Publicado: (2021)

Operative Treatment of Ascites in Cirrhosis of the Liver
Publicado: (1909)

Cannot write session to /tmp/vufind_sessions/sess_bu5dpqk5n3dmam1q79kd7kvh1j